Mr Saransh Chaudhary Shares Industry Perspectives Across Leading Editorial Platforms
Mr Saransh Chaudhary shares expert perspectives on India's API ecosystem and AI-driven drug discovery through articles published in Moneycontrol.com and Pharma Focus Asia.
Venus Remedies continues to strengthen its position as a thought leader in the pharmaceutical industry through insightful contributions. Mr Saransh Chaudhary, Executive Director & Chief Executive Officer, VMRC, continues to contribute to important conversations shaping the pharmaceutical and healthcare industry through leading editorial platforms.
His latest articles, published in Moneycontrol and Pharma Focus Asia, reflect the company's commitment to driving meaningful conversations around healthcare policy, pharmaceutical innovation, and the future of drug development.
Addressing India's API Dilemma
Mr. Chaudhary's opinion article, "India's API Dilemma: Resilience versus Competitiveness," was featured on Moneycontrol.com, one of India's leading financial and business news platforms.
In his writing, he examines the strategic challenges and opportunities surrounding India's active pharmaceutical ingredient (API) ecosystem. His perspective highlights the need to strike the right balance between building resilient supply chains and maintaining global competitiveness while maintaining the country's global competitiveness as a pharmaceutical exporter.
The article explores the importance of reducing vulnerabilities in critical pharmaceutical inputs while developing an ecosystem that is robust, competitive, and capable of responding to evolving global demands. By contributing to this important conversation, Venus Remedies continues to demonstrate its commitment to shaping the future of India's pharmaceutical ecosystem through evidence-based industry perspectives.
Exploring the Future of AI-Driven Drug Discovery
Mr Chaudhary's thought leadership also extends to the rapidly evolving landscape of pharmaceutical R&D. He authored an article titled "Beyond Trial and Error: How Precision Tools and AI are De-risking Drug Discovery and Development," in Pharma Focus Asia, an internationally renowned magazine.
The article explores how emerging technologies, including artificial intelligence, structural biology, CRISPR, predictive modelling, and integrated development ecosystems, are transforming conventional approaches to drug discovery and development into a faster, data-driven, and more resilient model.
It highlights how modern tools are enabling researchers to identify promising drug candidates with greater precision, reducing late-stage clinical failures, and improving the efficiency of drug development. This can help identify potential challenges sooner, optimise research pathways, and improve the prospects of translating promising scientific discoveries into successful therapies.
Advancing Venus Remedies' Thought Leadership
These publications reflect Venus Remedies' continued focus on sharing knowledge that extends beyond its business operations. Mr Saransh Chaudhary’s, Executive Director & Chief Executive Officer, VMRC, perspectives reinforce Venus Remedies' growing presence in conversations around pharmaceutical innovation, strategic resilience, technology-led R&D, and sustainable healthcare development
As Venus Remedies advances its innovation-driven journey, such contributions reaffirm its commitment to scientific excellence, responsible leadership, and creating meaningful impact through knowledge sharing and policy engagement.
